Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster

EMBO Rep. 2022 Sep 5;23(9):e55299. doi: 10.15252/embr.202255299. Epub 2022 Jul 7.

Abstract

Lifespan is determined by complex and tangled mechanisms that are largely unknown. The early postnatal stage has been proposed to play a role in lifespan, but its contribution is still controversial. Here, we show that a short rapamycin treatment during early life can prolong lifespan in Mus musculus and Drosophila melanogaster. Notably, the same treatment at later time points has no effect on lifespan, suggesting that a specific time window is involved in lifespan regulation. We also find that sulfotransferases are upregulated during early rapamycin treatment both in newborn mice and in Drosophila larvae, and transient dST1 overexpression in Drosophila larvae extends lifespan. Our findings unveil a novel link between early-life treatments and long-term effects on lifespan.

Keywords: aging; early-life treatment; mTOR; sulfotransferases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / physiology
  • Animals
  • Drosophila / physiology
  • Drosophila Proteins* / genetics
  • Drosophila melanogaster / genetics
  • Longevity* / physiology
  • Mice
  • Sirolimus / pharmacology

Substances

  • Drosophila Proteins
  • Sirolimus